Effects of Ginsenoside Rb1 on Serum Brain Natriuretic Peptide Level and Caspase‑3 Protein Expression in Cardiomyocytes of Rats with Chronic Heart Failure

ABSTRACT

Aim: The aim of this study was to evaluate the effects of ginsenoside Rb1 on the level of brain natriuretic peptide (BNP) in serum and the expression of caspase‑3 protein in the cardiomyocytes of CHF rats. Subjects and Methods: A total of 48 Wistar rats were divided into control, model, positive control (losartan), and ginsenoside Rb1 groups at random (n = 12). Abdominal aortic constriction was adopted for CHF modeling. Four weeks after surgery, ginsenoside Rb1 and losartan groups were intragastrically administered with 50 mg/ kg ginsenoside Rb1 and 4.5 mg/kg losartan daily, respectively. Control and model groups were given equal volumes of distilled water. Cardiac function indices, electrocardiographic signals, BNP level, heart weight, body weight, heart‑to‑body weight ratio, myocardial pathological changes, and caspase‑3 protein expression were compared. Results: In contrast to model group, heart rate, left ventricular end‑diastolic pressure, BNP level, and caspase‑3 protein expression of ginsenoside Rb1 and losartan groups notably dropped, whereas left ventricular systolic pressure and maximal rise/fall rate of the left ventricular pressure significantly rose (P < 0.05). The heart weight and heart‑to‑body weight ratio of ginsenoside Rb1 and losartan groups were evidently lower relative to those in the model group (P < 0.05). The ST segments of losartan and ginsenoside Rb1 groups fell after rise. Ginsenoside Rb1 inhibited focal cardiomyocyte necrosis and steatosis and relieved myocardial myofibrillar dissolution. It evidently decreased broken muscle bundles, as well as alleviated fibrosis and myocardial fibrosis. Conclusion: Ginsenoside Rb1 can improve the cardiac function of CHF rats, probably by inhibiting the apoptosis of cardiomyocytes.

KEYWORDS

• Brain natriuretic peptide
• cardiomyocyte
• caspase‑3
• chronic heart failure
• Ginsenoside Rb1
• Wistar rats

Showing references and in-text citations exactly as published.

• DOI10.4103/pm.pm_561_19Copy

RELATED ARTICLES

Matched on section and article type within this issue of Pharmacogn. Mag..

• Article · VOLUME 17, ISSUE 74Characterization of Secondary Metabolites in Different Parts of Ocimum gratissimum L. by in vitro Antioxidant Activity and High‑performance Liquid Chromatography–Diode‑array Detector AnalysisSharmistha Ganguly, Jyoti Kumar, Tapan Seal · pp. 209–215Original ArticleSame type: Article
• Article · VOLUME 17, ISSUE 74Therapeutic Targets and Biological Mechanisms of Curcumol on Atherosclerosis: A Study Based on Network Pharmacology Approach and Biological StudiesBaolian Ma, Shilin Yang, Junmao Li, Zhiqi Wen, Hui Ouyang, Wugang Zhang, Yulin Feng, Mingzhen He · pp. 216–222Original ArticleSame type: Article
• Article · VOLUME 17, ISSUE 74Rapid Qualitative and Quantitative Analysis of Volatile Components and Quality Identification of Amomi Fructus Based on Bionic Olfactory SystemHuaying Zhou, Zhong Li, Dehan Luo, Hamid Gholamhosseini, Bin Han, Hexian Wang · pp. 223–230Original ArticleSame type: Article
• Article · VOLUME 17, ISSUE 74Costunolide Attenuates Oxygen‑glucose Deprivation/ Reoxygenation‑Induced Apoptosis in Mouse Brain Slice through Inhibiting Caspase ExpressionHuixia Ma, Yafei Zhu, Zhengjun Zhang, Xinhui Zhang, Qipeng Zhao · pp. 231–235Original ArticleSame type: Article